Study about the response to the administration of a third dose of mRNA-1273 vaccine (COVID19 vaccine Moderna) in renal transplants with immunological failure initial to vaccination

Fundació Clinic per a la Recerca Biomèdica (FCRB)0 个研究点目标入组 80 人开始时间: 2021年9月23日最近更新: 2024年2月26日

适应症

试验速览

暂无简介。

•1. Age > 18 years;
•2. Male or female sex;
•3. Renal transplant with stable renal function in the last 2 months prior to study inclusion;
•4.Had received a full schedule of vaccination for SARS-CoV-2 with mRNA1273 vaccine (Moderna) and remained seronegative at 2 weeks after the second dose.
•5.Patient giving written informed consent.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 48
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 32

•1. Renal transplantation < 3 months;
•2. Pregnancy or lactation status;
•3. Rejection treated within the last 6 months;
•4. Presence of humoral immunity to SARS-CoV-2 defined as the presence of specific IgM/IgG.

发起方

Fundació Clinic per a la Recerca Biomèdica (FCRB)